Michael E RyttingDepartment of Pediatrics and Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: Asparaginase preparations deplete asparagine in acute lymphoblastic leukemia (ALL) blasts. Asparaginase in its various forms is an important component of treatment regimens for pediatric ALL. Recently, interest and use of asparaginase in adult patients with ALL has increased, particularly in young adults. There is much less information on asparaginase use and toxicity in adult compared with pediatric populations. This review surveys prior published studies of the three most commonly used asparagine preparations as used in adult patients, and discusses important toxicities encountered in adult patients who receive ...
__Abstract__ Intensified and effective asparaginase therapy is very important in modern treatment...
Acute lymphoblastic leukemia (ALL) is a form of blood cancer that affects white blood cells and is a...
International audiencePURPOSE: The GRASPALL/GRAALL-SA2-2008 Phase II trial evaluated the safety and ...
Acute lymphoblastic leukemia (ALL) is a malignancy of lymphoid progenitor cells occurring at an annu...
The inclusion of asparaginase in chemotherapy regimens to treat acute lymphoblastic leukemia (ALL) h...
Asparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblas...
l-Asparaginase (EC 3.5.1.1) was first used as a component of combination drug therapies to treat acu...
Asparaginase is an integral component of multiagent chemotherapy regimens for the treatment of child...
The history of asparaginase clinical use is inextricably linked to the improvement of treatment prog...
Abstract Cerebral venous thrombosis (CVT) covers up to a third of all venous thromboses (VTs) detect...
<div><p>Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied...
International audiencel-asparaginase encapsulated within erythrocytes (GRASPA(®) ) should allow seru...
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic ...
Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether...
__Abstract__ Intensified and effective asparaginase therapy is very important in modern treatment...
Acute lymphoblastic leukemia (ALL) is a form of blood cancer that affects white blood cells and is a...
International audiencePURPOSE: The GRASPALL/GRAALL-SA2-2008 Phase II trial evaluated the safety and ...
Acute lymphoblastic leukemia (ALL) is a malignancy of lymphoid progenitor cells occurring at an annu...
The inclusion of asparaginase in chemotherapy regimens to treat acute lymphoblastic leukemia (ALL) h...
Asparaginase is one of the most important chemotherapeutic agents against pediatric acute lymphoblas...
l-Asparaginase (EC 3.5.1.1) was first used as a component of combination drug therapies to treat acu...
Asparaginase is an integral component of multiagent chemotherapy regimens for the treatment of child...
The history of asparaginase clinical use is inextricably linked to the improvement of treatment prog...
Abstract Cerebral venous thrombosis (CVT) covers up to a third of all venous thromboses (VTs) detect...
<div><p>Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied...
International audiencel-asparaginase encapsulated within erythrocytes (GRASPA(®) ) should allow seru...
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic ...
Although L-asparaginase related hyperglycemia is well known adverse event, it is not studied whether...
__Abstract__ Intensified and effective asparaginase therapy is very important in modern treatment...
Acute lymphoblastic leukemia (ALL) is a form of blood cancer that affects white blood cells and is a...
International audiencePURPOSE: The GRASPALL/GRAALL-SA2-2008 Phase II trial evaluated the safety and ...